Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: Bioorg Med Chem Lett. 2021 Apr 23;43:128061. doi: 10.1016/j.bmcl.2021.128061

Figure 3.

Figure 3.

Selectivity profile of CDK9 PROTAC 2. Western blot analysis showing dose-dependent (24 h) (A) and time-dependent (1 μM) (B) effects of PROTAC 2 in HEK293 cells. In vitro cell-free IC50 (C) and KD (D) profiling of inhibitor 11 and PROTAC 2, respectively.